LivaNova

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LivaNova and other ETFs, options, and stocks.

About LIVN

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the following segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support (ACS).

CEO

Vladimir A. Makatsaria

CEOVladimir A. Makatsaria

Employees

3,300

Employees3,300

Headquarters

London, Greater London

HeadquartersLondon, Greater London

Founded

2015

Founded2015

Employees

3,300

Employees3,300

LIVN Key Statistics

Market cap

3.46B

Market cap3.46B

Price-Earnings ratio

-14.14

Price-Earnings ratio-14.14

Dividend yield

—

Dividend yield—

Average volume

834.65K

Average volume834.65K

High today

$63.65

High today$63.65

Low today

$61.62

Low today$61.62

Open price

$63.43

Open price$63.43

Volume

501.09K

Volume501.09K

52 Week high

$71.92

52 Week high$71.92

52 Week low

$32.48

52 Week low$32.48

Stock Snapshot

LivaNova(LIVN) stock is priced at $63.30, giving the company a market capitalization of 3.46B. It carries a P/E multiple of -14.14.

On 2026-03-26, LivaNova(LIVN) stock traded between a low of $61.62 and a high of $63.65. Shares are currently priced at $63.30, which is +2.7% above the low and -0.5% below the high.

The LivaNova(LIVN)'s current trading volume is 501.09K, compared to an average daily volume of 834.65K.

During the past year, LivaNova(LIVN) stock moved between $32.48 at its lowest and $71.92 at its peak.

LIVN News

Simply Wall St 1d

A Look At LivaNova Valuation After Recent Share Price Weakness

Advertisement LivaNova Stock: Event Trigger and Initial Takeaways LivaNova (LIVN) has drawn investor attention after recent share performance data showed a 1...

Simply Wall St 5d

LivaNova’s Aura6000 FDA Win Reshapes Obstructive Sleep Apnea Opportunity

FDA grants premarket approval to LivaNova's aura6000 System for adult patients with moderate to severe Obstructive Sleep Apnea who do not benefit from standard...

TipRanks 7d

LivaNova granted premarket approval for aura6000 System by FDA

LivaNova (LIVN) announced the FDA granted premarket approval for the aura6000 System for the treatment of adult patients with moderate to severe Obstructive Sle...

Analyst ratings

73%

of 11 ratings

Buy

72.7%

Hold

27.3%

Sell

People also own

Based on the portfolios of people who own LIVN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.